URYCVE traded at 2.45119 this Monday November 2nd, decreasing 0.00597 or 0.24 percent since the previous trading session. Looking back, over the last four weeks, URYCVE lost 0.93 percent. Over the last 12 months, its price rose by 1.80 percent. Looking ahead, we forecast URYCVE to be priced at 2.45607 by the end of this quarter and at 2.47258 in one year, according to Trading Economics global macro models projections and analysts expectations.